Trial Site Detail

 

Drug:
Lenvatinib
Trial:
Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure (LENVAGIST)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

Institut de Cancérologie de Lorraine

     
Vandoeuvre-les-Nancy , Meurthe et Moselle 54511
France

 

Principal Investigator:
Maria Rios, Dr.
Contact:
m.rios@nancy.unicancer.fr
Activation Status of this Site:
Active
Notes about this Site:
Institut de Cancérologie de Lorraine Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.